MicroTrace BioAI

MicroTrace BioAIMicroTrace BioAIMicroTrace BioAI

MicroTrace BioAI

MicroTrace BioAIMicroTrace BioAIMicroTrace BioAI

Next-Gen AI for Minimal Residue Disease & Early Cancer Detection

Next-Gen AI for Minimal Residue Disease & Early Cancer DetectionNext-Gen AI for Minimal Residue Disease & Early Cancer DetectionNext-Gen AI for Minimal Residue Disease & Early Cancer Detection

Revolutionizing liquid biopsy with ultra-sensitive NGS technology

Discover Our Solutions

Next-Gen AI for Minimal Residue Disease & Early Cancer Detection

Next-Gen AI for Minimal Residue Disease & Early Cancer DetectionNext-Gen AI for Minimal Residue Disease & Early Cancer DetectionNext-Gen AI for Minimal Residue Disease & Early Cancer Detection

Revolutionizing liquid biopsy with ultra-sensitive NGS technology

Discover Our Solutions

About MicroTrace BioAI

Innovative Research

At MicroTrace BioAI, we are dedicated to groundbreaking research that combines artificial intelligence with methylation-based next-generation sequencing for ultra-sensitive Minimal Residual Disease/Early Cancer Detection, achieving 100× higher sensitivity than current standards and detecting tumor signals at fractions as low as 1 in 1,000,000 without prior tumor profiling. Our goal is to bring Silicon Valley–grade AI and liquid biopsy innovation into scalable clinical products for China and Asian markets.

Contact Us

Better yet, see us in person!

We love our customers, so feel free to visit during normal business hours.

MicroTrace BioAI

Hours

Open today

09:00 – 17:00

Drop us a line!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Subscribe

Copyright © 2025 MicroTrace BioAI - All Rights Reserved.

Powered by